2023
DOI: 10.1016/j.htct.2021.07.007
|View full text |Cite
|
Sign up to set email alerts
|

Serological characteristics of Lewis antibodies and their clinical significance – A case series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 12 publications
0
2
0
Order By: Relevance
“…RBCs acquire Lewis antigens via adsorption, when the cells come into contact with the soluble forms of the antigens [21]. The addition of a fucose moiety directly on type 1 carbohydrate chains by the Le gene results in the synthesis of the Lea antigen, whereas the addition of a fucose moiety on H antigens results in the formation of the Leb antigen [20,22]. Since the Leb antigen requires the H antigen backbone, which must be synthesized by the Se gene in epithelial cells and secretions, the Leb antigen is not present in non-secretors.…”
Section: Overview Of the Abo Blood Group Lewis Antigens And Secretor ...mentioning
confidence: 99%
“…RBCs acquire Lewis antigens via adsorption, when the cells come into contact with the soluble forms of the antigens [21]. The addition of a fucose moiety directly on type 1 carbohydrate chains by the Le gene results in the synthesis of the Lea antigen, whereas the addition of a fucose moiety on H antigens results in the formation of the Leb antigen [20,22]. Since the Leb antigen requires the H antigen backbone, which must be synthesized by the Se gene in epithelial cells and secretions, the Leb antigen is not present in non-secretors.…”
Section: Overview Of the Abo Blood Group Lewis Antigens And Secretor ...mentioning
confidence: 99%
“…According to Boateng et al [ 123 ], the frequency of alloantibody development in patients with SCD is as high as 76% compared to the general population [ 124 ]. The frequency of red blood cell alloimmunisation in SCD patients may not be the same in every part of the world due to blood transfusion rates, ethnic mismatch, and the age of the initial transfusion [ 20 , 125 , 126 ].…”
Section: The Cause Of High Alloimmunisation In Scd Patientsmentioning
confidence: 99%